CBU
PRAX icon

CIBC Bancorp USA’s Praxis Precision Medicines PRAX Stock Holding History

CIBC Bancorp USA’s Portfolio PRAX Stock Details PRAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$468K Buy
1,397
+85
+6% +$26.9K ﹤0.01% 1334
2026
Q1 		$423K Buy
+1,312
New +$406K ﹤0.01% 1283

Other funds holding PRAX

JT
Jupiter Topco New York $245B AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

CIBC Bancorp USA's PRAX Position: Q2 2026 in Review

CIBC Bancorp USA increased its Praxis Precision Medicines (PRAX) stake by 6.5% in Q2 2026, buying an estimated $26.9K and bringing the position to 1,397 shares worth $468K. The position accounts for ﹤0.01% of the portfolio, ranked #1334.

CIBC Bancorp USA first reported a position in PRAX in Q1 2026 and has held it in 2 quarters since. 309 funds tracked by Wall St. Rank hold PRAX as of Q2 2026.

  • CIBC Bancorp USA held 1,397 shares of Praxis Precision Medicines worth $468K as of Q2 2026.
  • CIBC Bancorp USA bought 85 Praxis Precision Medicines shares in Q2 2026, an estimated $26.9K.
  • Praxis Precision Medicines made up ﹤0.01% of CIBC Bancorp USA's portfolio in Q2 2026, its #1334 holding.
  • CIBC Bancorp USA first reported a position in Praxis Precision Medicines in Q1 2026 and has held it in 2 quarters since.
  • 309 funds tracked by Wall St. Rank held Praxis Precision Medicines as of Q2 2026.

Based on CIBC Bancorp USA's 13F filing for Q2 2026, filed 13 Aug 2026.